{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:06:14Z","timestamp":1785269174904,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012357","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000}}],"reference-count":59,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012357.pub2","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T02:17:03Z","timestamp":1549937823000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication"],"prefix":"10.1002","volume":"2019","author":[{"given":"Lu\u00eds Eduardo S","family":"Fontes","sequence":"first","affiliation":[{"name":"Petr\u00f3polis Medical School; Department of Evidence-Based Medicine, Intensive Care, Gastroenterology; Av Barao do Rio Branco, 1003 Petr\u00f3polis RJ Brazil 25680-120"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Luiza C","family":"Martimbianco","sequence":"additional","affiliation":[{"name":"Centro de Estudos de Sa\u00fade Baseada em Evid\u00eancias e Avalia\u00e7\u00e3o Tecnol\u00f3gica em Sa\u00fade; Cochrane Brazil; Rua Borges Lagoa, 564 cj 63 S\u00e3o Paulo SP Brazil 04038-000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Zanin","sequence":"additional","affiliation":[{"name":"Hospital Alcides Carneiro; Intensive Care Unit; Petr\u00f3polis RJ Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Riera","sequence":"additional","affiliation":[{"name":"Centro de Estudos de Sa\u00fade Baseada em Evid\u00eancias e Avalia\u00e7\u00e3o Tecnol\u00f3gica em Sa\u00fade; Cochrane Brazil; Rua Borges Lagoa, 564 cj 63 S\u00e3o Paulo SP Brazil 04038-000"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,2,12]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD012357.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cgh.2010.05.006","article-title":"Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial","volume":"8","author":"Cammarota","year":"2010","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD012357.pub2-BIB0002|cit2","first-page":"334","article-title":"Histopathologic and morphologic evaluations of resistant strains of H. pylori, and consequent new therapeutic approaches: usefulness of N-acetil-cysteine and culture-guided antibiotics","volume":"14","author":"Cammarota","year":"2009","journal-title":"Helicobacter"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD012357.pub2-BIB0003|cit3","first-page":"A345W","article-title":"Pre-treatment with N-acetil-cysteine and culture-guided rescue therapy for eradication of Helicobacter pylori infection","volume":"136","author":"Cammarota","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/2277-9175.140403","article-title":"N-acetyl cysteine as an adjunct to standard anti-Helicobacter pylori eradication regimen in patients with dyspepsia: A prospective randomized, open-label trial","volume":"3","author":"Emami","year":"2014","journal-title":"Advanced Biomedical Research"},{"issue":"11","key":"10.1002\/14651858.CD012357.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/01.smj.0000182486.39913.da","article-title":"Effect of N-acetyl cysteine onHelicobacter pylori","volume":"98","author":"Gurbuz","year":"2005","journal-title":"Southern Medical Journal"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"540271","DOI":"10.1155\/2015\/540271","article-title":"An additive effect of oral N-acetyl cysteine on eradication of Helicobacter pylori","volume":"2015","author":"Hamidian","year":"2015","journal-title":"Journal of Pathogens"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0007|cit7","first-page":"185","article-title":"N-acetylcysteine does not enhance eradication of Helicobacter pylori by amoxycillin","volume":"5","author":"Hansen","year":"1994","journal-title":"European Journal of Clinical Research"},{"issue":"1","key":"10.1002\/14651858.CD012357.pub2-BIB0008|cit8","first-page":"107","article-title":"Effect of oral N-acetyl cysteine on eradication of Helicobacter pylori in patients with dyspepsia","volume":"59","author":"Karbasi","year":"2013","journal-title":"Minerva Gastroenterologica e Dietologica"},{"issue":"4","key":"10.1002\/14651858.CD012357.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5009\/gnl15048","article-title":"Effects of N-acetylcysteine on first-line sequential therapy for Helicobacter pylori Infection: A randomized controlled pilot trial","volume":"10","author":"Yoon","year":"2016","journal-title":"Gut and Liver"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD012357.pub2-BIB0010|cit10","first-page":"A4301","article-title":"The effects of N-acetylcysteine on first-line 10-day sequential therapy for Helicobacter pylori infection: A randomized controlled trial","volume":"2","author":"Yoon","year":"2014","journal-title":"United European Gastroenterology Journal"},{"issue":"31-32","key":"10.1002\/14651858.CD012357.pub2-BIB0011|cit11","first-page":"1391","article-title":"N-acetylcysteine improves eradication of Helicobacter pylori by omeprazole\/amoxicillin in cigarette smokers","volume":"124","author":"Zala","year":"1994","journal-title":"Schweizerische Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0012|cit12","unstructured":"NCT01572597 Increased re-eradication rate of Helicobacter pylori by adding N-acetylcysteine or metronidazole to the triple therapy Helicobacter pylori clinicaltrials.gov\/ct2\/show\/NCT01572597"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0013|cit13","unstructured":"NCT02249546 Efficacy of acetylcysteine-containing triple therapy in the first line of Helicobacter pylori infection Helicobacter pylori clinicaltrials.gov\/ct2\/show\/NCT02249546"},{"issue":"4","key":"10.1002\/14651858.CD012357.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.00893-06","article-title":"Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters","volume":"51","author":"Aslam","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"10.1002\/14651858.CD012357.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"752","DOI":"10.5301\/ijao.5000024","article-title":"Role of antibiofilm-antimicrobial agents in controlling device-related infections","volume":"34","author":"Aslam","year":"2011","journal-title":"International Journal of Artificial Organs"},{"issue":"2","key":"10.1002\/14651858.CD012357.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/scientificamerican0205-38","article-title":"An endangered species in the stomach","volume":"292","author":"Blaser","year":"2005","journal-title":"Scientific American"},{"issue":"2","key":"10.1002\/14651858.CD012357.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00606662","article-title":"Pharmacokinetics of N-acetylcysteine in man","volume":"31","author":"Borgstrom","year":"1986","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/hel.12071","article-title":"Diagnosis and epidemiology of Helicobacter pylori infection","volume":"18 Suppl 1","author":"Calvet","year":"2013","journal-title":"Helicobacter"},{"issue":"9","key":"10.1002\/14651858.CD012357.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cgh.2010.05.006","article-title":"Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial","volume":"8","author":"Cammarota","year":"2010","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD012357.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2036.2012.05165.x","article-title":"Review article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infection","volume":"36","author":"Cammarota","year":"2012","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD012357.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.gassur.2005.10.019","article-title":"Identification of Helicobacter pylori biofilms in human gastric mucosa","volume":"10","author":"Carron","year":"2006","journal-title":"Journal of Gastrointestinal Surgery"},{"issue":"3","key":"10.1002\/14651858.CD012357.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.lpm.2010.11.008","article-title":"Role of Helicobacter pylori infection in iron deficiency anemia","volume":"40","author":"Chaabane","year":"2011","journal-title":"Presse Medicale"},{"issue":"24","key":"10.1002\/14651858.CD012357.pub2-BIB0023|cit23","first-page":"6735","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention","volume":"52","author":"Correa","year":"1992","journal-title":"Cancer Research"},{"issue":"6","key":"10.1002\/14651858.CD012357.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.gassur.2005.12.009","article-title":"Presence and density of Helicobacter pylori biofilms in human gastric mucosa in patients with peptic ulcer disease","volume":"10","author":"Coticchia","year":"2006","journal-title":"Journal of Gastrointestinal Surgery"},{"issue":"3","key":"10.1002\/14651858.CD012357.pub2-BIB0025|cit25","first-page":"382","article-title":"Pharmacokinetics and bioavailability of oral acetylcysteine in healthy volunteers","volume":"39","author":"Caro","year":"1989","journal-title":"Arzneimittel-Forschung"},{"issue":"4","key":"10.1002\/14651858.CD012357.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1128\/CMR.10.4.720","article-title":"Helicobacter pylori","volume":"10","author":"Dunn","year":"1997","journal-title":"Clinical Microbiology Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012357.pub2-BIB0027|cit27","first-page":"302","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht IV\/ Florence Consensus Report","volume":"61","author":"European Helicobacter Study Group (EHSG)","year":"2012","journal-title":"GUT"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0028|cit28","unstructured":"Cochrane Editorial Resources Committee (ERC) ERC data collection form for intervention review for RCTs only www.community-archive.cochrane.org\/sites\/default\/files\/uploads\/forums\/u389\/ERC%20data%20collection%20form%20for%20intervention%20reviews%20for%20RCTs%20only.doc"},{"issue":"2","key":"10.1002\/14651858.CD012357.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5662\/wjm.v5.i2.101","article-title":"Current Helicobacter pylori treatment in 2014","volume":"5","author":"Ermis","year":"2015","journal-title":"World Journal of Methodology"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4137\/PMC.S14459","article-title":"Antibiotics and bacterial resistance in the 21st century","volume":"6","author":"Fair","year":"2014","journal-title":"Perspectives in medicinal chemistry"},{"issue":"9","key":"10.1002\/14651858.CD012357.pub2-BIB0031|cit31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012357","article-title":"N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication","author":"Fontes","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"19","key":"10.1002\/14651858.CD012357.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.3748\/wjg.v20.i19.5632","article-title":"Biofilm and Helicobacter pylori: from environment to human host","volume":"20","author":"Garcia","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0033|cit33","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"8","key":"10.1002\/14651858.CD012357.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham","year":"2010","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD012357.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1378\/chest.129.1.174","article-title":"Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force","volume":"129","author":"Guyatt","year":"2006","journal-title":"Chest"},{"issue":"7","key":"10.1002\/14651858.CD012357.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1462-5822.2009.01323.x","article-title":"Evolving concepts in biofilm infections","volume":"11","author":"Hall-Stoodley","year":"2009","journal-title":"Cellular Microbiology"},{"issue":"7414","key":"10.1002\/14651858.CD012357.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0038|cit38","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0039|cit39","unstructured":"Higgins JPT Altman DG Sterne JAC Cochrane Statistical Methods Group Cochrane Bias Methods Group Chapter 8.5: The Cochrane Collaboration's tool for assessing risk of bias. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD012357.pub2-BIB0040|cit40","first-page":"299","article-title":"Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline","volume":"20","author":"Hunt","year":"2011","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"issue":"7","key":"10.1002\/14651858.CD012357.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.dld.2017.03.010","article-title":"Smoking increases the likelihood of Helicobacter pylori treatment failure","volume":"49","author":"Itskoviz","year":"2017","journal-title":"Digestive and Liver Disease"},{"issue":"1","key":"10.1002\/14651858.CD012357.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bj.2015.06.002","article-title":"Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis","volume":"39","author":"Kao","year":"2016","journal-title":"Biomedical Journal"},{"issue":"2","key":"10.1002\/14651858.CD012357.pub2-BIB0043|cit43","first-page":"114","article-title":"Clinical applications of N-acetylcysteine","volume":"3","author":"Kelly","year":"1998","journal-title":"Alternative Medicine Review"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2036.11.s1.5.x","article-title":"Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer","volume":"11 Suppl 1","author":"Kuipers","year":"1997","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"9699","key":"10.1002\/14651858.CD012357.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(09)60938-7","article-title":"Peptic ulcer disease","volume":"374","author":"Malfertheiner","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD012357.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection \u2014 the Maastricht IV\/ Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD012357.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"issue":"8390","key":"10.1002\/14651858.CD012357.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD012357.pub2-BIB0049|cit49","first-page":"265","article-title":"N-acetylcysteine: multiple clinical applications","volume":"80","author":"Millea","year":"2009","journal-title":"American Family Physician"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"17","key":"10.1002\/14651858.CD012357.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3748\/wjg.v18.i17.2105","article-title":"Study of Helicobacter pylori genotype status in saliva, dental plaques, stool and gastric biopsy samples","volume":"18","author":"Momtaz","year":"2012","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0052|cit52","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0053|cit53","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD012357.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/gut.51.4.490","article-title":"Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats","volume":"51","author":"Sherwood","year":"2002","journal-title":"Gut"},{"issue":"6","key":"10.1002\/14651858.CD012357.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2008-07-167155","article-title":"Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review","volume":"113","author":"Stasi","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD012357.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000350719","article-title":"Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection","volume":"88","author":"Venerito","year":"2013","journal-title":"Digestion"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0057|cit57","first-page":"S90","article-title":"Assessment of in vitro biofilm formation by Helicobacter pylori","volume":"25 Suppl 1","author":"Yonezawa","year":"2010","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD012357.pub2-BIB0058|cit58","first-page":"1","article-title":"Effects of N-acetylcysteine on first-Line sequential therapy for Helicobacter pylori infection: a randomized controlled pilot trial","volume":"9","author":"Yoon","year":"2015","journal-title":"Gut and Liver"},{"issue":"3","key":"10.1002\/14651858.CD012357.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MCG.0b013e31829f2e25","article-title":"Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up","volume":"48","author":"Zhao","year":"2014","journal-title":"Journal of Clinical Gastroenterology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012357.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T02:47:20Z","timestamp":1735526840000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012357.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Upper GI and Pancreatic Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,12]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012357.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,12]]}}}